CERTYNEX IFRS ACADEMY

Vectane, a laboratory, is developing a manufacturing process for a vaccine; the recognition criteria of the development phase are met. Which of the following expenditures must be excluded from the cost of the intangible asset?

Salaries of the chemists assigned full time to the process.

Reagents and laboratory services consumed by the project.

Fees paid to register the patent protecting the process.

The cost of batches rejected because of identified inefficiencies.